Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
6
67%
Ph early_phase_1
1
11%
Ph not_applicable
1
11%
Ph phase_2
1
11%

Phase Distribution

7

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
6(66.7%)
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(4)

Detailed Status

Completed4
Not yet recruiting3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (11.1%)
Phase 16 (66.7%)
Phase 21 (11.1%)
N/A1 (11.1%)

Trials by Status

not_yet_recruiting333%
completed444%
recruiting222%

Recent Activity

Clinical Trials (9)

Showing 9 of 9 trials

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9